• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,094.07 291.17
( 0.38%)
Global Indices
Nasdaq
51,585.70 72.15
(0.14%)
Dow Jones
7,521.58 80.48
(1.08%)
Hang Seng
72,454.13 1,204.07
(1.69%)
Nikkei 225
10,441.93 78.66
(0.76%)
Forex
USD-INR
94.39 -0.12
(-0.13%)
EUR-INR
108.40 -1.03
(-0.94%)
GBP-INR
125.08 -1.43
(-1.13%)
JPY-INR
0.59 0.00
(-0.50%)

EQUITY - MARKET SCREENER

Sreeleathers Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
535601
INE099F01013
214.9534675
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SREEL
17.49
503.39
EPS(TTM)
Face Value()
Div & Yield %
12.43
10
0.46
 

Shilpa Medicare enters into development and supply agreement with NXI Therapeutics AG
Feb 13,2026
Shilpa Medicare (SML) has entered into a binding agreement with NXI Therapeutics AG based out of Basel, Switzerland for development, supply of a New Chemical Entity (NCE). Under the terms of the strategic collaboration, SML will support both development – including first-in-human clinical studies – as well as long-term commercial supply with GMP manufacturing.